'Ovarian cancer cell lines' diaporamas de présentation

Genomic signatures to guide the use of chemotherapeutics

Genomic signatures to guide the use of chemotherapeutics. Authors: Anil Potti et. al Presenter: Jong Cheol Jeong. Motivation. What will be happened if ineffective chemotherapy is used?. Increasing the probability of side effects. Decreasing the quality of life. Purpose.

404 views • 23 slides

Zhenfeng Duan Massachusetts General Hospital Center for Sarcoma and Connective Tissue Oncology

IDENTIFICATION OF DUAL-SPECIFICITY TYROSINE-(Y)-PHOSPHORYLATION REGULATED KINASE 1B (DYRK1B) AS A POTENTIAL THERAPEUTIC TARGET IN OSTEOSARCOMA. Zhenfeng Duan Massachusetts General Hospital Center for Sarcoma and Connective Tissue Oncology. Protein Kinase .

336 views • 16 slides

Acquire ovarian cancer cell lines from various repository

Supplementary Figure 1. A. Acquire ovarian cancer cell lines from various repository ATCC (6), CRT (2), DSMZ (2), ECACC (7), Kyoto U (24), RIKEN (1). Establish EM Phenotypic Characterisation. Validate EMT Marker Expression. Cell line expansion & banking SGOCL (43). Create EMT Spectrum.

207 views • 8 slides

Actin

Supplementary Figure S1. Lee et al. PEA-15. Actin. Hey. 2774. RMG-1. KOC-7c. OVTOKO. OVCA420. OVCA432. SKOV3.ip1.

202 views • 5 slides

The Powell Lab is actively investigating the application of immune-based therapy for cancer. Building on interrogations in basic T cell biology in the lab, bench-to-bedside translational immunology is being developed, with a strong focus on T cell-based therapy for cancer.

131 views • 1 slides